EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, BRIBF: Brii Bioscience Ltd

07 Jan 2026
LAST:

0.1882

CHANGE:
 0.00		OPEN:
0.1882		HIGH:
0.1882		ASK:
0.0000		VOLUME:
1.4K
CHG(%):
0.80		PREV:
0.1867		LOW:
0.1882		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Jan 260.18820.18820.18820.18821.4K

PROFILE

Name:Brii Bioscience Ltd
About:Brii Biosciences Limited focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States. The company develops BRII-179, a recombinant protein-based HBV immunotherapeutic candidate; Elebsiran, an investigational subcutaneously administered HBV-targeting siRNA; and Tobevibart, an investigational subcutaneously administered HBV-neutralizing monoclonal antibody which are in Phase 2 of the development stage for functional cure of HBV for Hepatitis B; and BRII-732 that has completed Phase 1 clinical trial and BRII-753, which is in preclinical stage for the treatment of HIV. It also develops BRII-693 for the treatment of multi-drug resistant/extensive drug resistant (MDR/XDR) gram-negative bacterial infections, which has completed Phase 1; and Epetraborole for oral treatment for patients with chronic NTM lung disease. Brii Biosciences Limited was incorporated in 2017 and is headquartered in Beijing, China.
Sector:Healthcare
Industry:Biotechnology
Address:Building 7, International Science Park, Beijing, China, 100192
Website:https://www.briibio.com
CIK:0001965619
FIGI:BBG0147C6Q48

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.2214.6%
MA10:0.2533.4%
Week High:0.190.0%
Week Low:0.190.0%